Clinical Trial Update: PRO-232 in Patients Subjected to Cataract Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating PRO-232 for cataract extraction is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• PRO-232

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Cataract Extraction | Phase 3 | Status: RECRUITING